Medical research

Disease-causing tangle could spawn new materials

When most people hear the word amyloid, they immediately think of Alzheimer's disease. And indeed, it was in the brains of Alzheimer's patients that these dense protein masses were first identified. But it turns out that ...

Biomedical technology

Promising eco-friendly plug to treat nosebleeds

Nosebleeds, also known as epistaxis, are one of the most frequent otolaryngologic (ENT) emergencies worldwide. It is estimated that 60% of the world's population will experience an episode of epistaxis at least once in their ...

Vaccination

FDA experts weigh authorizing Novavax COVID-19 vaccine in US

A panel of experts convened by the US drug regulator was meeting Tuesday to consider authorizing the Novavax COVID-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine ...

Biomedical technology

Antibiotic levels can be measured in breath for first time

A team of engineers and biotechnologists at the University of Freiburg has for the first time shown in mammals that the concentration of antibiotics in the body can be determined using breath samples. The breath measurements ...

Diseases, Conditions, Syndromes

Inroads to a better Ebola vaccine

As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses.

Medical research

Scientists find potential treatment for Friedreich's ataxia

Researchers at UT Southwestern Medical Center have identified synthetic RNA and DNA that reverses the protein deficiency causing Friedreich's ataxia, a neurological disease for which there is currently no cure.

page 2 from 3